Aro Biotherapeutics
Swapnil Kulkarni is a professional specializing in the field of bioconjugation and oligonucleotide platform optimization. With a Ph.D. in Medicinal Chemistry, Swapnil has extensive experience in protein purification, characterization, and engineering. They have also worked on developing protease inhibitors and antimicrobial peptides for various applications. With a background in pharmaceutical sciences and experience in process development and technology transfer, Swapnil's expertise spans across academia and industry in the pharmaceutical and biotechnology sectors.
This person is not in any teams
Aro Biotherapeutics
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.